In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 9th, 2004 | 21 | Yes |
( -)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid
(+-)-2-(p-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid
(1)-2-(4-Chlorophenyl)benzoxazole-5-propionic acid
2-(2-(4-Chlorophenyl)-1,3-benzoxazol-5-yl)propanoic acid
2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid
2-(p-Chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic acid
2-[2-(4-Chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid
5-Benzoxazoleacetic acid, 2-(4-chlorophenyl)-.alpha.-methyl-
5-benzoxazoleacetic acid, 2-(4-chlorophenyl)-a-methyl-
5-Benzoxazoleacetic acid, 2-(4-chlorophenyl)-alpha-methyl, (+-)-
5-Benzoxazoleacetic acid, 2-(4-chlorophenyl)-alpha-methyl-
51234-28-7; Benoxaprofen (USAN/INN); D03080; Oraflex (TN)
51234-86-7 (mono-hydrochloride salt)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.53 | -0.61 | -46.47 | 0 | 4 | -1 | 66 | 300.721 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.17e-02 g/l | DrugBank-withdrawn |
PUBCHEM_PATENT_ID | EP0000276A1; EP0042249A2; EP0072462A2; EP0098041A2; EP0101124A1; EP0109036A1; EP0114886A1; EP0123739A2; EP0138481A2; EP0138481B1; EP0140709A2; EP0140709B1; EP0147847A2; EP0149545A2; EP0152004A1; EP0158083A2; EP0160173A1; EP0162330A1; EP0162330B1; EP017477 | IBM Patent Data |